Michael Barthold is the global leader of the TruMatch CMF patient specific products and services for Depuy Synthes Medical Devices, a division of Johnson and Johnson. Michael has over 16 years of experience in the healthcare and medical device industry, including various repsonsibities in project management, research and develop, and operational management. Over the last ten years, Michael has lead and developed the patient specific products and services, providing a comprehensive platform of virtual pre-operative planning services, patient specific surgical guides, and patient specific implants. This has involved internal development and strategic partnerships in technologies, such as additive manaufacturing, CAD / CAM software, and PLM software. Michael has also lead the program for developing customized instruments for surgeons to help improve meet their specific needs and improve surgical efficiency. Michael earned a BS Degree in Materials Science and Engineering from Drexel Uiversity.
Position and employment
Dr. Chen Ching Kit, MBBS, MMed (Paed Med), MRCPCH (UK)
Senior Consultant, Cardiology Service
Director, Cardiomyopathy and Heart Function Programme
Department of Paediatric Subspecialties, KK Women's and Children's Hospital
Medical Director, National Paediatric Heart Transplant and Mechanical Cardiac Support Programme, Singapore
Adj Asst Professor of Paediatrics, Yong Loo Lin School of Medicine, NUS
Dr Chen Ching Kit is a consultant paediatric cardiologist at KK Women’s and Children’s Hospital (KKH). He graduated with a Bachelor of Medicine and Surgery from the National University of Singapore, and pursued post-graduate training in paediatrics and paediatric cardiology at KKH. He underwent two years of fellowship in paediatric heart failure and heart transplantation at the Hospital for Sick Children in Toronto, Canada. His other areas of interest and expertise include exercise echocardiography, foetal echocardiography and 3D printing of heart models. Dr Chen is also an adjunct assistant professor with the Department of Paediatrics at the Yong Loo Lin School of Medicine, National University of Singapore. A recipient of the Philip Witchel Memorial Research Fellowship in Pediatric Heart Failure 2013 (Canada), his current research interests include dilated cardiomyopathy, exercise echocardiography in cardiomyopathy and congenital heart diseases, and the impact of de novo anti-HLA antibodies in paediatric heart transplantation.
Matthieu is a visionary entrepreneur with great people management and communication skills. Under his leadership FEops has transformed from a small academic spin-off into a fast-growing venture capital backed gazelle in the medtech sector. He completed his degree in Engineering at the University of Ghent in 2002 and gained his PhD in 2008 for his research on cardiovascular device and procedure modeling. In 2009 he followed the general management program ‘Technology Transfer’ at Vlerick Leuven Gent Management School. Matthieu is author of several high-impact scientific publications.
Alexander De Croo (°1975) is currently Deputy Prime Minister and Minister of Development Cooperation, Digital Agenda, Post and Telecom in the Belgian Federal Cabinet. From 2012 to 2014 he was Deputy Prime Minister and Minister of Pensions. Before taking the office of Deputy Prime Minister, Alexander De Croo was Party Chairman of Open Vld, the Flemish liberal-democrats. In 2010, he was elected Senator, scoring third in the popular vote in Flanders.
In 2015, he was selected as Young Global Leader by the World Economic Forum (WEF). He is also member of the Global Agenda Council on Europa at the WEF.
Prior to politics, Alexander De Croo was an active entrepreneur in the field of intellectual property rights. He started his professional career as a business consultant for The Boston Consulting Group.
Alexander holds a degree in Business Engineering from the Free University of Brussels and an MBA from Kellogg School of Management (Northwestern University, Chicago).
Brigitte de Vet is the Vice President of Materialise Medical and a member of the Executive Committee of Materialise.
She joined Materialise in 2016 with almost 20 years of experience in the healthcare and life science sector and a solid track record in leading and transforming companies. Her focus on customers, innovation, improved operational efficiency and execution has led to significant growth.
Prior to joining Materialise, Brigitte held various management, sales, operations and marketing positions at Johnson & Johnson, ultimately serving as General Manager for Cordis in Germany and VP EMEA for Cordis Neurovascular.
She was also CEO of the Acertys Group where she was behind a significant effort to improve operational efficiencies, strengthen the product portfolio and stimulate growth. In addition, with her vision and drive she led a number of companies through periods of significant change.
Brigitte holds an MBA from INSEAD and a BA with a major in Engineering from HEC Liege.
Félix S. España, started as a licensed graduate in Optics & Optometry at Complutense University of Madrid in 1988. Five years later he got a Degree Diploma in Marketing Strategy at Universidad Politécnica de Madrid which helped him to develop his career in different positions within the Optical Industry. He continued his education with an MBA at ESIC some years later.
After working for several lens suppliers and launching and managing the second largest Spanish optical retail chain (Optica 2.000) with more than 100 shops and 850 employees, he joined Hoya Lens Iberia as Marketing Manager.
In October 2011 he joined Hoya Vision Care Europe as EMEA Trade Marketing Manager, becoming the Manager of NewMedia Team in early 2015.
His career has allowed him to see the optical industry from many different angles, a key factor to invent and develop tools and systems that help the Eye Care Professionals to improve their performance and results as well as to enhance the consumer experience in the store.
Dr Henney has a PhD in Medicine and many years’ academic research experience, studying cardiovascular disease at the pathological, cellular, molecular and genetic level in laboratories in London, Cambridge and Oxford. He then moved into industry, spending 13 years with AstraZeneca. Ultimately leading global programmes exploring strategic
improvements aimed at reducing drug failure in development, he created and headed a new department that focused on pathway mapping and modelling, which evolved to establish the practice of Systems Biology, supporting projects in discovery and development.
Dr Henney has extensive experience in directing and managing large, complex teams across
disciplinary, cultural and geographic boundaries, latterly in the area of Systems Biology and Systems Medicine. His experience in this area led to an invitation to direct the major €50M German national flagship programme, The Virtual Liver Network. At the time, the largest Systems Biology programme in Europe, it involved management of over 200 contributing
scientists from a range of disciplines, including clinicians, in 36 independent institutions, including industry, located across Germany. Operating as a distributed team, rather than a consortium, the leaders successfully implemented a range of modelling approaches focused on liver function and dysfunction that reached from the lab bench into clinical studies on volunteers and patients.
Following the end of the VLN Programme, Dr Henney was elected to be part-time Executive Director of the Virtual Physiological Human Institute, a not-for-profit organisation promoting the use of computational modelling and simulation to interpret quantitative biological information and understand the dynamics of biological and physiological function. As part of that role, he was responsible for establishing a new partnership with industry, The Avicenna Alliance for Predictive Medicine, a not-for-profit organisation that focuses on developing a policy framework supporting the use of in silico technologies in medicine, and of which he is now Secretary General.
Professor, Shanghai Jiaotong University School of Medicine
Director, Shanghai Institute of Pediatric Congenital Heart Disease
Member, World Pediatric Heart Surgery Management Committee
Member, American Association for Thoracic Surgery
Chairman, The standing committee of the Chinese pediatric surgery
Senior doctor, Department of Thoracic and Cardiovascular Surgery, Shanghai Children’s Medical Center
09/1972-07/1975, Medical BA, Shanghai Second Medical College, Shanghai, China
09/1985-07/1988, MD and PhD Medicine, Shanghai Second Medical University, Shanghai, China
MD and PhD Advisor Wenxiang Ding
Appointments at Hospital
08/1975-08/1985, Resident Doctor, Xinhua Hospital, Shanghai, China
09/1985-05/1989, Doctor-in-charge, Xinhua Hospital, Shanghai, China
06/1989-04/1996, Associate senior doctor, Associate professor, Xinhua Hospital, Shanghai, China
05/1996-09/1998, Senior doctor, professor, Xinhua Hospital, Shanghai, China
10/1998-01/2004, Vice President, Shanghai Children’s Medical Center, Shanghai, China
04/2001-05/2007, Vice President, Xinhua Hospital, Shanghai, China
02/2004-12/2012, President, Shanghai Children’s Medical Center, Shanghai, China
Member, Editorial Board of Chinese Journal of Thoracic and Cardiovascular Surgery
Member, Editorial Board of Chinese Journal of Pediatric Surgery
Member, Editorial Board of World Journal of Pediatrics
Associate Editor, World Journal for Pediatric& Congenital Heart Surgery
Ayishwariya Menon graduated with an MEng. in biomedical engineering from Imperial College London, UK where she was awarded the Governor’s Prize, and the Student Centenary Prize. She went on to work for the Acrobot Company Ltd., UK in the field of orthopaedic surgical navigation and robotics. She further specialized in computer assisted surgery with her work at Materialise N.V, Belgium applying Materialise’s core technology of 3D printing to orthopaedic surgery. She has worked on a number of development projects on guided surgery and has spoken at various international conferences. She then spent a few years in her home country, Malaysia, heading up the clinical business for Materialise. Along with her team, she was excited to be able to bring innovations in the clinical field to the Asia Pacific region. Currently, she is working on a novel development project in respiratory medicine out of Materialise USA in close collaboration with the University of Michigan. Ayishwariya is passionate about using technology to touch lives and is a strong advocate of multi-disciplinary collaboration to make this possible.
Clinical Utility and Value of 3D printing at a Larger Quaternary Referral Center: The Mayo Clinic
Jonathan M. Morris, M.D. Co-director Anatomic Modeling Laboratory, and a member of the Division of Neuroradiology. Dr. Morris received an Innovation Award from the Radiology Department to develop 3D anatomic models in collaboration with Dr. Matsumoto and Joel Kuhlmann and the Division of Engineering in 2007.
In July 2012 Dr. Morris was a leader with Dr. Matsumoto of Pediatric Radiology and Linda Nesberg in establishing the Anatomic Modeling Laboratory within the Department of Radiology and currently serves as its co-director. The laboratory has produced over 118 models to date, mainly focused on complex surgical cases. Dr. Morris is actively exploring research, educational and forensic applications.
Dr. Morris’s neuroradiology practice includes neuroradiology, minimally invasive spine procedures, interventional oncology,
and pain management. Dr. Morris received his M.D. from Howard University College of Medicine in 2001. He completed a research fellowship with the NIH in 2001-2002 in the Neurosurgical Division. Dr. Morris did his residency and fellowship programs in Radiology and Neuroradiology at Mayo Clinic before joining the staff in 2007. He has authored and coauthored 55 peer reviewed journal articles, 20 conference proceedings and abstracts and two book chapters.
Richard G. Ohye, M.D. is the Associate Chair of the Department of Cardiac Surgery and Head of the Section of Pediatric Cardiovascular Surgery at the University of Michigan Medical School, and co-Director of the University of Michigan C. S. Mott Children’s Hospital Congenital Heart Center. The U-M Congenital Heart Center is internationally recognized as a leader in the care of patients with congenital heart disease, performing 500-600 open-heart and 1000 total operations each year.
Dr. Ohye’s current research activities consist of several projects through the Michigan Congenital Heart Outcomes Research and Discovery Program (M-CHORD), as well as being the co-Principle Investigator of the Section’s research activities in the NIH-sponsored Pediatric Heart Network (PHN). Through the PHN, Dr. Ohye is the Study Chair of the multi-institutional Single Ventricle Reconstruction Trial, the first multi-institutional randomized clinical trial performed in congenital heart surgery. He also has a strong interest in innovation and cardiac device development.
Mark Palmer is a Senior Principal Scientist leading Biomechanics and Modeling in the Core Technologies Group within the Strategy and Scientific Operations organization for Medtronic, plc. Dr. Palmer received his BS in Mechanical & Aerospace Engineering from Princeton University, dual Masters in Mechanical Engineering and Biomedical Engineering as well as MD and PhD in Mechanical Engineering from the University of Michigan. Following graduation, Dr Palmer worked as an entrepreneur for 3 years leveraging his custom, fully coupled, multiscale finite element modeling code for research and consulting in the areas of composites and the analyses of age related changes in skeletal muscle. Dr. Palmer then returned to academia serving for 5 years as a tenure track faculty member at the University of Michigan with dual appointments in Kinesiology and Biomedical Engineering. While serving as a faculty member, Dr. Palmer's research was focused on image-based modeling for Orthopedic injury mechanisms and procedures. In 2014, Dr. Palmer was recruited to Medtronic where his current role includes serving as an R&D Consultant and Technical Advisor for Medtronic Business Units world-wide, identifying and managing external collaborations, and leading the long range R&T strategy for human simulation.
Alireza Parandian leads the global business strategy for additive manufactured wearables at Materialise. After completing his PhD research in emerging technologies and strategy articulation at the Delft University of Technology, he co-founded a company called InnovationFab in 2012 where he gained extensive experience in facilitating the use of new technologies to create breakthrough product innovations and led multiple European funded projects on Digital Fabrication. Since 2014, his multidisciplinary background has led him to further develop Materialise’s strong co-creation culture, resulting in long-standing collaborations and truly meaningful applications for Additive Manufacturing.
Aalpen A. Patel, MD, FSIR
A physician engineer, active teacher and researcher, he has a special interest in 3D printing, machine and deep learning, mathematical modeling of biological processes, and informatics. He is the Chairman of Radiology for Geisinger Health System, Vice Chair of Informatics and Quality and the Medical Director for 3D Imaging and Printing laboratory. Dr. Patel has published 90 research articles, review articles, textbook chapters and abstracts and has given several lectures at regional, national and international radiology meetings.
Dr. Patel is an electrical engineer and clinically he is an Interventional Radiologist and his clinical research interests include dialysis access management and interventional oncology. He trained at Temple University Hospital and M. D. Anderson Cancer Center. Dr. Patel began his career in 2001 as Assistant Professor of Radiology at the University of Pennsylvania School of Medicine and an Interventional Radiologist at Hospital of the University of Pennsylvania.
He led Radiology and Interventional Radiology simulation program at Penn Medicine Clinical Simulation Center. He has been in various leadership positions at Geisinger for past 6 years. He is boarded in Diagnostic Radiology, Interventional Radiology and Clinical Informatics and a Fellow in the Society of Interventional Radiology.
Andreas Saar is a Vice President in the Manufacturing Engineering Solution business segment of Siemens PLM Software. In his current role, Andreas is responsible for the Additive Manufacturing Program Initiative within Siemens PLM Software which includes the definition, implementation and market introduction of a global end-to-end additive manufacturing solution based on Siemens software and technology.
In this role, Andreas also coordinates and manages Additive Manufacturing research, technology adoption, and partner / vendor relationships across Siemens business units.
Andreas has 30+ years of experience in manufacturing and software development. He joined the company in 1994 and has since then worked in various leading positions across product and business development with a focus on Digital Manufacturing.
Andreas holds a Diploma in Mechanical Engineering and Business from the University Darmstadt/Germany.
Thomas Schouman, M.D., Ph.D., is a maxillofacial surgeon working at Pitié-Salpêtrière University Hospital in Paris.
The Department of Maxillofacial Surgery is the biggest facial trauma center and one of the top oral cancer treatment centers in France. Consequently, facial reconstruction is also a major field. Dr. Schouman is dedicated to reconstructive and orthognathic surgery and is leading the management of trauma cases. He was involved in the development of custom-made medical devices through a long-standing research collaboration with OBL-Materialise, which led to the routine use of such custom-made guides or implants since 2010 for fibula free flap reconstruction, orthognathic cases or trauma sequels for instance.
Consultant orthopaedic surgeon since 1991 specialising in hip surgery.
Major clinical interests; diagnosis and management of infection, reconstruction of the pelvis and femur following major bone loss
Philip Tack holds a master in business engineering and a bachelor in medicine and combined those interests in pursuing a PhD in Health Economics focusing on the value of medical 3D printing.
Materialise CEO Fried Vancraen began his career in 1985 after receiving a Master of Science in Electro-Mechanical Engineering. Working as a Research Engineer and Consultant at the Research Institute of the Belgian Metalworking Industry, Fried discovered 3D Printing. Passionate about this new technology, and firm in his belief that it could help create a better and healthier world, he founded Materialise in July 1990. Fried holds several patents related to the technical and medical applications of 3D Printing and remains committed to using the technology to make positive changes in people's lives. In recent years, Fried has been awarded the RTAM/SME Industry Achievement Award, the highest honor in the 3D Printing industry, has been selected as the most influential person in Additive Manufacturing by industry professionals and TCT Magazine, and has been listed one of the five leading players in his sector by the Financial Times. He is also the recipient of a 2013 Visionaries! Award from the Museum of Art and Design in New York.
Jos Vander Sloten (°1962) obtained his MSc and PhD in mechanical engineering from the Katholieke Universiteit Leuven (KU Leuven) in 1985 and 1990 respectively. Currently he is full professor within the Division of Biomechanics at KU Leuven. He chairs the Leuven Medical Technology Centre (L-MTC), which he founded in 2008. His teaching assignments are engineering mechanics, problem solving and engineering design, computer integrated surgery systems. From 2006 to 2012 he served as programme director of the Master in Biomedical Engineering at KU Leuven.
His research interests are computer applications in musculoskeletal biomechanics and computer integrated surgery, on which he authored more than 160 journal papers. He is member of the council of the Belgian Society for Medical and Biological Engineering and Computing, and a former council member of the European Society of Biomechanics. In the European Alliance for Medical and Biological Engineering and Science (EAMBES) he served as secretary-general (2003-2004), president-elect (2005) and president (2006). He was recently elected Founding Fellow of EAMBES.
He is a co-founder of the spin-off company Custom8, member of the board of directors of the company Materialise NV
Peter Verschueren has a Master in Electro-Mechanical Engineering Sciences, a one-year specialization in Biomedical Engineering Techniques and a PhD in Biomedical Engineering from the University of Leuven.
He joined Materialise 9 years ago and is currently the Medical Product Director. His expertise and interest are rooted in medical imaging, image-based 3D reconstruction and 3D printing technologies, and their application in the clinical setting.
He manages the Product Managers responsible for both software and hardware-based medical applications. His international team provides the link between the user’s needs and the solutions Materialise can provide or develop.
He is author and inventor of multiple medical device innovations and related patents and ongoing patent applications.
Marco Viceconti holds the chair of Biomechanics at the Department of Mechanical Engineering of the University of Sheffield, UK, and serves as Executive Director of the Insigneo Institute for in silico Medicine (www.insigneo.org), a joint initiative of the University of Sheffield and the Sheffield Teaching Hospital NHS Foundation Trust. He is also professor associate in the department of Oncology and Metabolism. Prof Viceconti is an expert of musculoskeletal biomechanics in general, and in particular in the use of subject-specific modelling to support the medical decision. He is one of the key figures in the Virtual Physiological Human (VPH) community: he is the President of the VPH Institute, an international no-profit organisation that coordinates this research community, and has recently concluded the coordination of the Avicenna action, which road-mapped the emerging topic of “in silico clinical trials”, where subject-specific modelling is used in the development and assessment of biomedical products.
Erik has 18 years experience as IP and regulatory lawyer. After his traineeship in the antitrust department of the European Commission he worked at international law firms in Brussels and Amsterdam. He is one of the founding partners of EU life sciences niche firm Axon in 2011 and of the Alliance of European Life Sciences Law Firms.
His practice comprises advice to and litigation for clients from the pharmaceutical, medical device and biotechnology industries in legal, regulatory, intellectual property and anti-trust matters.
Erik is member of Eucomed’s Data Protection Task Force and COCIR’s data protection committee.
He sits on European Commission’s Medical Devices Expert Group on New and Emerging Technology’s Special Interest Groups on mHealth, 3D printing and Horizon Technologies.
Erik is member of the mHealth Stakeholder Group chaired by DG Connect of the European Commission
He is visiting teacher at several universities on the subjects of regulation of medical bioprinting and robotics in healthcare.
Dee Dee Wang, M.D., FACC, FASE, FSCCT is a graduate of Wayne State University School of Medicine and completed her internal medicine residency and served as chief medical resident at the University of Michigan. She completed her general cardiology fellowship at Henry Ford Hospital, and went on to do an additional fellowship in Advanced Cardiac Imaging with an emphasis on structural heart and transcatheter valve replacement therapies.
Dr. Wang is a Level 3 Cocats trained in Echocardiography (with 3D TEE), Nuclear, and Cardiac CTA; and a Level 2 Cocats trained in Cardiac MRI and Cardiac PET. She specializes in Interventional Imaging in Structural Heart Interventions including Transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures.
Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging and 3D printing for high-risk Structural Heart Interventions. She is currently the Director of Structural Heart Imaging at Henry Ford Hospital’s Center for Structural Heart Disease, Medical Director of 3D Printing at the Henry Ford Innovations Institute, Clinical Assistant Professor with Wayne State University’s School of Medicine and the Director of the Cardiac CT CoreLab at Henry Ford Hospital’s Center for Structural Heart Disease.